Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triplex® Vaccine in Adults With HIV and CMV
NCT05099965Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2021
- Primary completion
- Nov 2024
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Triplex in cytomegalovirus infection (CMV), sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2021; status: completed.
02
Drugs
Triplex
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT05099965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05099965.